Laura Victor

Laura Victor has six years of work experience. Laura began their career in 2014 as an Asbestos & Mass Toxic Tort Bankruptcy Paralegal for Weitz & Luxenberg PC. In 2015, they worked as a Research Assistant (temporary) for the University of Michigan School of Public Health. From 2016 to 2019, they worked at the ECOG-ACRIN Cancer Research Group as a Protocol Associate I and Protocol Associate II. In 2019, they were promoted to Clinical Trial Associate and Senior Clinical Trial Associate at Cadent Therapeutics (acquired by Novartis). In 2021, they moved to Ikena Oncology as a Clinical Research Associate. Currently, they are a Clinical Trial Manager at Palleon Pharmaceuticals.

Laura Victor attended SUNY Geneseo from 2011 to 2014, where they earned a Bachelor's Degree in Anthropology.